Saol Therapeutics (pronounced “Sail”) is a privately-held, specialty biotech pharmaceutical company with operations in both Roswell, GA and Dublin, Ireland. Saol, focused on neuroscience (spasticity) and rare disease, is committed to providing and advancing therapeutic options for patients and the physicians treating these populations. For more information, visit www.saolrx.com.
Location: United States, Georgia, Roswell
Employees: 51-200
Founded date: 2015
Investors 2
| Date | Name | Website |
| - | Avego | avego.com |
| - | DFW Capita... | dfwcapital... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 24.03.2023 | Saol Therapeutics enhances its IP portfolio | Saol Therapeutics enhances its IP portfolio for Dichloroacetate (DCA; SL-1009) in Glioblastoma and R... | dfwcapital... |